Amylyx Pharmaceuticals, Inc. (AMLX)
NASDAQ: AMLX · Real-Time Price · USD
3.600
+0.100 (2.86%)
At close: Jan 17, 2025, 4:00 PM
3.610
+0.010 (0.28%)
After-hours: Jan 17, 2025, 5:03 PM EST
Amylyx Pharmaceuticals Employees
Amylyx Pharmaceuticals had 384 employees as of December 31, 2023. The number of employees increased by 122 or 46.56% compared to the previous year.
Employees
384
Change (1Y)
122
Growth (1Y)
46.56%
Revenue / Employee
$511,680
Profits / Employee
-$675,693
Market Cap
245.10M
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 384 | 122 | 46.56% |
Dec 31, 2022 | 262 | 57 | 27.80% |
Dec 31, 2021 | 205 | 171 | 502.94% |
Dec 31, 2020 | 34 | - | - |
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
AMLX News
- 6 days ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Amylyx Pharmaceuticals, Inc. (AMLX) and Encourages Shareholders to Learn More About the Investigation - Accesswire
- 7 days ago - Amylyx Pharmaceuticals, Inc. (AMLX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - Accesswire
- 8 days ago - Bronstein, Gewirtz & Grossman, LLC Encourages Amylyx Pharmaceuticals, Inc. (AMLX) Shareholders to Inquire about Securities Investigation - Accesswire
- 10 days ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating Amylyx Pharmaceuticals, Inc. (AMLX) And Encourages Shareholders to Connect - Accesswire
- 10 days ago - Amylyx Pharmaceuticals Announces Pricing of Public Offering of Common Stock - Business Wire
- 11 days ago - Amylyx Pharmaceuticals Announces Proposed Public Offering of Common Stock - Business Wire
- 12 days ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Amylyx Pharmaceuticals, Inc. (AMLX) and Encourages Investors to Learn More About the Investigation - Accesswire
- 13 days ago - Amylyx Pharmaceuticals, Inc. (AMLX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Shareholders to Contact the Firm to Learn More About the Investigation - Accesswire